Shinichi Tate

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Topics

Ulcerative Colitis

Neoadjuvant Chemotherapy

Endometrial Cancer

Top Venues

Journal of gynecologic oncology

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuya Kobayashi, Kyoko Nishikimi, Akira Mitsuhashi, Hongying Piao, Ayumu Matsuoka, Satoyo Otsuka, Shinichi Tate, Makio Shozu, Hirokazu Usui
Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma. Genes, chromosomes & cancer (2023)
Naoko Nomoto, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori, Kenichi Sakurai
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 14 (23) (2022)
Naoko Nomoto, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori, Kenichi Sakurai
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 14 (23) (2022)
Naoko Nomoto, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori, Kenichi Sakurai
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 14 (23) (2022)
Ayumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, Tastuya Kobayashi, Satoyo Otsuka, Makio Shozu
Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell Tumors. Cancers 14 (18) (2022)
Naoko Nomoto, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori, Kenichi Sakurai
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 14 (23) (2022)
Kyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer. Journal of gynecologic oncology 33 (3) (2022)
Kyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian Cancer. Cancers 13 (16) (2021)
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Yuki Shiko, Yoshihito Ozawa, Yohei Kawasaki, Makio Shozu
Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma. Cancers 13 (13) (2021)
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin. Cancers 13 (4) (2021)
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
Introduction of rectosigmoid colectomy improves survival outcomes in early-stage ovarian cancer patients. International journal of clinical oncology 26 (5) (2021)
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Kazuyoshi Kato, Yutaka Takahashi, Makio Shozu
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial. Journal of gynecologic oncology 32 (1) (2020)
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Makio Shozu
Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence. International journal of clinical oncology 25 (9) (2020)
Shinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, Ayumu Matsuoka, Michiyo Kambe, Takako Kiyokawa, Makio Shozu
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer. Journal of gynecologic oncology 31 (3) (2019)
Kyoko Nishikimi, Shinichi Tate, Kazuyoshi Kato, Ayumu Matsuoka, Makio Shozu
Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely. Journal of gynecologic oncology 31 (1) (2019)